首页 › 基金 › Affinity Asset Advisors, LLC › MDGL

Affinity Asset Advisors, LLC 对 MDGL 的持仓历史

MADRIGAL PHARMACEUTICALS INC · 医疗保健

Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 MDGL(MADRIGAL PHARMACEUTICALS INC)30,000 股,市值约 US$15.1M,约占其申报组合的 0.70%,在其申报持仓中市值排名第 38 位。 Affinity Asset Advisors, LLC 最近 13 个申报季度中有 13 个季度披露了 MDGL 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)30.00K 股
申报持仓市值$15.12M
组合权重0.70%
首次申报Q3 2023
最近变动减持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Affinity Asset Advisors, LLC 对 MDGL 的持仓演变

Affinity Asset Advisors, LLC 于 Q3 2023 首次披露 MDGL 持仓:85,000 股(约 US$12.4M)。 该持仓在 Q3 2025 达到峰值 115,000 股,市值约 US$52.7M。 在 13 次申报中,Affinity Asset Advisors, LLC 4 次增持、7 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 30,000 股、市值约 US$15.1M,环比减持 -10,000 股。。 持仓曾出现大幅变动:Q3 2025 增持约 44% (随后一个季度股价上涨 27%)、Q4 2025 减持约 73% (随后一个季度股价下跌 10%)、Q1 2026 增持约 77% (随后一个季度股价上涨 3%)。

逐季持仓明细

季度股数金额变化
Q3 2023 85.00K $12.41M 新进
Q4 2023 100.00K $23.14M 增持
Q1 2024 115.00K $30.71M 增持
Q2 2024 110.00K $30.82M 减持
Q3 2024 100.00K $21.22M 减持
Q4 2024 82.50K $25.46M 减持
Q1 2025 80.00K $26.50M 减持
Q2 2025 80.00K $24.21M 持有
Q3 2025 115.00K $52.75M 增持
Q4 2025 31.13K $18.13M 减持
Q1 2026 55.00K $28.79M 增持
Q2 2026 40.00K $21.48M 减持
Q3 2026 30.00K $15.12M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MDGL 与 13F 数据

MDGL(MADRIGAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 MDGL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), 骏利亨德森集团 (US$1.05B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MDGL 的基金

查看 MDGL 的全部基金持有人 →

常见问题

How long has Affinity Asset Advisors, LLC held MDGL?

Affinity Asset Advisors, LLC has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Affinity Asset Advisors, LLC's current position in MDGL?

As of Q3 2026, Affinity Asset Advisors, LLC holds 30.00K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $15.12M, representing 0.70% of its reported portfolio and ranking #38.

Has Affinity Asset Advisors, LLC been buying or selling MDGL?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC reduced its position in MDGL. The position peaked in Q3 2025 at 115.00K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, 骏利亨德森集团, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.